In vivo toxicity studies of europium hydroxide nanorods in mice

Toxicology and Applied Pharmacology

Volumn 240, Issue 1, 2009, Pages 88-98

  Patra, Chitta Ranjan ^a   Abdel Moneim, Soha S ^b   Wang, Enfeng ^a   Dutta, Shamit ^a   Patra, Sujata ^a   Eshed, Michal ^c   Mukherjee, Priyabrata ^a,b   Gedanken, Aharon ^c   Shah, Vijay H ^b   Mukhopadhyay, Debabrata ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic   (United States)

^c BAR ILAN UNIVERSITY   (Israel)

Author keywords

EuIII(OH)3; Europium(III)hydroxide nanorods; Histology; HUVECs; ICPMS; In vivo toxicity; Microwave

Indexed keywords

ASPARTATE AMINOTRANSFERASE; EUROPIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; ENZYME ANALYSIS; HISTOPATHOLOGY; IN VIVO STUDY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; EUROPIUM; HUMANS; HYDROXIDES; MALE; MICE; MICE, INBRED C57BL; NANOTUBES;

MUS;

EID: 69749098872     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.07.009     Document Type: Article

References (76)

1. Alivisatos A.P., Johnsson K.P., Peng X.G., Wilson T.E., Loweth C.J., Bruchez M.P., and Schultz P.G. Organization of 'nanocrystal molecules' using DNA. Nature 382 (1996) 609-611
2. Alivisatos P. The use of nanocrystals in biological detection. Nat. Biotechnol. 22 (2004) 47-52
3. Authors. Lanthanides in medicine special issue. Chem. Soc. Rev. 35 (2006) 493-576
4. Banerjee T., Mitra S., Singh A.K., Sharma R.K., and Maitra A. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int. J. Pharm. 243 (2002) 93-105
5. Basu S., Nagy J.A., Pal S., Vasile E., Eckelhoefer I.A., Bliss V.S., Manseau E.J., Dasgupta P.S., Dvorak H.F., and Mukhopadhyay D. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growthfactor. Nat. Med. 7 (2001) 569-574
6. Bruce D.W., Hietbrink B.E., and DuBois K.P. The acute mammalian toxicity of rare earth nitrates and oxides. Toxicol. Appl. Pharmacol. 5 (1963) 750
7. Bruchez M., Moronne M., Gin P., Weiss S., and Alivisatos A.P. Semiconductor nanocrystals as fluorescent biological labels. Science 281 (1998) 2013-2016
8. Chavakis E., and Dimmeler S. Regulation of endothelial cell survival and apoptosis during angiogenesis. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 887-893
9. Chen J.P., Patil S., Seal S., and McGinnis J.F. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nature Nanotechnol. 1 (2006) 142-150
10. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Ipe B.I., Bawendi M.G., and Frangioni J.V. Renal clearance of quantum dots. Nature Biotechnol. 25 (2007) 1165-1170
11. Craighead H. Applications: Biological, Medical and Health (2000), Kluwer Academic Publishers, Boston
12. Dardik R., Loscalzo J., Eskaraev R., and Inbal A. Molecular mechanisms underlying the proangiogenic effect of factor XIII. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 526-532
13. Derfus A.M., Chan W.C.W., and Bhatia S.N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett. 4 (2004) 11-18
14. Ebrahimian T.G., Heymes C., You D., Blanc-Brude O., Mees B., Waeckel L., Duriez M., Vilar J., Brandes R.P., Levy B.I., Shah A.M., and Silvestre J.S. NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. American Journal of Pathology 169 (2006) 719-728
15. Fang Y.P., Xu A.W., Song R.Q., Zhang H.X., You L.P., Yu J.C., and Liu H.Q. Systematic synthesis and characterization of single-crystal lanthanide orthophosphate nanowires. J. Am. Chem.Soc.125 (2003) 16025-16034
16. Folkman J. Tumor ngiogenesis: role in regulation of tumor growth. Symp. Soc. Dev. Biol. 30 (1974) 43-52
17. Folkman J. Diagnostic and therapeutic applications of angiogenesis research. Comptes Rendus De L Academie Des Sciences Serie Iii-Sciences De La Vie-Life Sciences 316 (1993) 914-918
18. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1 (1995) 27-31
19. Folkman J., and Shing Y. Angiogenesis. J. Biol. Chem. 267 (1992) 10931-10934
20. Gao X.H., Cui Y.Y., Levenson R.M., Chung L.W.K., and Nie S.M. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22 (2004) 969-976
21. Gao X.H., Yang L.L., Petros J.A., Marshal F.F., Simons J.W., and Nie S.M. In vivo molecular and cellular imaging with quantum dots. Curr. Opin. Biotechnol.16 (2005) 63-72
22. Hainfeld J.F., Slatkin D.N., Focella T.M., and Smilowitz H.M. Gold nanoparticles: a new X-ray contrast agent. Br. J. Radiol. 79 (2006) 248-253
23. Haley T.J., Komesu N., Colvin G., Koste L., and Upham H.C. Pharmacology and toxicology of europium chloride. J. Pharma. Sci. 54 (1965) 643-645
24. Hirano S., and Suzuki K.T. Exposure, metabolism, and toxicity of rare earths and related compounds. Environ. Health Perspect. Suppl.104 (1996) 85-95
25. Huang M.H., Mao S., Feick H., Yan H.Q., Wu Y.Y., Kind H., Weber E., Russo R., and Yang P.D. Room-temperature ultraviolet nanowire nanolasers. Science 292 (2001) 1897-1899
26. Huston S.L., Lengerich E.J., Conlisk E., and Passaro K. Trends in ischemic heart disease death rates for blacks and whites United States, 1981-1995 (Reprinted from MMWR, vol 47, pg 945-949, 1998). Jama-Journal of the American Medical Association (JAMA) 281 (1999) 28-29
27. Isner J.M., and Losordo D.W. Therapeutic angiogenesis for heart failure. Nat. Med. 5 (1999) 491-492
28. Jain K.K. Nanotechnology in clinical laboratory diagnostics. Clin. Chim. Acta 358 (2005) 37-54
29. Jain K.K. Nanotechnology-based drug delivery for cancer. Technol. Cancer Res. Treat. 4 (2005) 407-416
30. Jaiswal J.K., Mattoussi H., Mauro J.M., and Simon S.M. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol. 21 (2003) 47-51
31. Jones D.W., Chambless L.E., Folsom A.R., Heiss G., Hutchinson R.G., Sharrett A.R., Szklo M., and Taylor H.A. Risk factors for coronary heart disease in African Americans- The Atherosclerosis Risk in Communities study, 1987-1997. Arch. Int. Med. 162 (2002) 2565-2571
32. Kim J.S., Yoon dagger T.J., Yu K.N., Kim B.G., Park S.J., Kim H.W., Lee K.H., Park S.B., Lee J.K., and Cho M.H. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol. Sci. 89 (2006) 338-347 doi:10.1093/toxsci/kfj027
33. Limpeanchob N., Tiyaboonchai W., Lamlertthon S., Viyoch J., and Jaipan S. Efficacy and Toxicity of Amphotericin B-Chitosan Nanoparticles in Mice with Induced Systemic Candidiasis. Naresuan University Journal 14 (2006) 27-34
34. Longmire M., Choyke P.L., and Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 3 (2008) 703-717
35. Matsumurainoue T., Tanabe M., Minami T., and Ohashi T. A Remarkably Rapid Synthesis of Ruthenium(Ii) Polypyridine Complexes by Microwave Irradiation. Chem. Lett. (1994) 2443-2446
36. Mazloumi M., Shahcheraghi N., Kajbafvala A., Zanganeh S., Lak A., Mohajerani M.S., and Sadrnezhaad S.K. 3D bundles of self-assembled lanthanum hydroxide nanorods via a rapid microwave-assisted route. J. Alloys Comp. 473 (2009) 283-287
37. McDowell E.M., and Trump B.F. Histologic fixatives suitable for. diagnostic light and electron microscopy. Arch. Path. Lab. Med. 10 (1976) 405-414
38. Medintz I.L., Uyeda H.T., Goldman E.R., and Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 4 (2005) 435-446
39. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., Sundaresan G., Wu A.M., Gambhir S.S., and Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307 (2005) 538-544
40. Misra S.N., Gagnani M.A., Devi I., and Shukla R.S. Biological and clinical aspects of lanthanide coordination compounds. Bioinorg. Chem. Appl. 2 (2004) 155-192
41. Moghimi S.M. Exploiting Bone-Marrow Microvascular Structure for Drug-Delivery and Future Therapies. Adv. Drug. Deliv. Rev. 17 (1995) 61-73
42. Moghimi S.M. Mechanisms of splenic clearance of blood-cells and particles - towards development of new splenotropic agents. Adv. Drug. Deliv. Rev. 17 (1995) 103-115
43. Moghimi S.M., and Hunter A.C. Capture of stealth nanoparticles by the body's defences. Crit. Rev. Ther. Drug Carrier Syst. 18 (2001) 527-550
44. Moghimi S.M., Hunter A.C., and Murray J.C. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev. 53 (2001) 283-318
45. Nakamura Y., Tsumura Y., Shibata T., and Ito Y. Differences in behavior among the chlorides of seven rare earth elements administered intravenously to rats. Toxicol. 37 (1997)
46. Ogawa Y., Suzuki S., Naito K., Saito M., Kamata E., Hirose A., Ono A., Kaneko T., Chiba M., and Inaba Y.e.a. Toxicity study of europium chloride in rats. J-Environ-Pathol-Toxicol-Oncol. 14 (1995) 1-19
47. Palasz A., and Czekaj P. Toxicological and cytophysiological aspects of lanthanides action. Acta Biochimica Polonica 47 (2000) 1107-1114
48. Parak W.J., Gerion D., Pellegrino T., Zanchet D., Micheel C., Williams S.C., Boudreau R., Le Gros M.A., Larabell C.A., and Alivisatos A.P. Biological applications of colloidal nanocrystals. Nanotechnology 14 (2003) R15-R27
49. Patra C.R., Alexandra G., Patra S., Jacob D.S., Gedanken A., Landau A., and Gofer Y. Microwave approach for the synthesis of rhabdophane-type lanthanide orthophosphate (Ln = La, Ce, Nd, Sm, Eu, Gd and Tb) nanorods under solvothermal conditions. New J. Chem. 29 (2005) 733-739
50. Patra C.R., Bhattacharya R., Patra S., Basu S., Mukherjee P., and Mukhopadhyay D. Inorganic phosphate nanorods are a novel fluorescent label in cell biology. J. Nanobiotechnology. 4 (2006)
51. Patra C.R., Bhattacharya R., Patra S., Basu S., Mukherjee P., and Mukhopadhyay D. Lanthanide phosphate nanorods as inorganic fluorescent labels in cell biology research. Clin. Chem. 53 (2007) 2029-2031
52. Patra C.R., Bhattacharya R., Mukhopadhyay D., and Mukherjee P. Application of gold nanoparticles for targeted therapy in cancer. J. Biomed. Nanotechnol. 4 (2008) 99-132
53. Patra C.R., Bhattacharya R., Patra S., Vlahakis N.E., Gabashvili A., Koltypin Y., Gedanken A., Mukherjee P., and Mukhopadhyay D. Pro-angiogenic properties of europium(III) hydroxide nanorods. Adv. Mater. 20 (2008) 753-756
54. Patra C.R., Bhattacharya R., Wang E., Katarya A., Lau J.S., Dutta S., Muders M., Wang S., Buhrow S.A., Safgren S.L., Yaszemski M.J., Reid J.M., Ames M.M., Mukherjee P., and Mukhopadhyay D. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res. 68 (2008) 1970-1978
55. Patra C.R., Cao S., Safgren S., Bhattacharya R., Ames M., Shah V., Reid J.M., and Mukherjee P. Intracellular fate of a targeted delivery system. J. Biomed. Nanotechnol. 4 (2008) 508-514
56. Patra C.R., Mukherjee P., and Mukhopadhyay D. Application of Lanthanide (Ln = Eu and Tb) Nanoparticles in Biology and Medicine (2009), Nova Science Publishers, NY
57. Patra C.R., Verma R., Kumar S., Greipp P.R., Mukhopadhyay D., and Mukherjee P. Fabrication of gold nanoparticle for potential application in multiple myeloma. J. Biomed. Nanotechnol. 4 (2008) 499-507
58. Prescher J.A., and Bertozzi C.R. Chemistry in living systems. Nat. Chem. Biol. 1 (2005) 13-21
59. Reinders M.E.J., Sho M., Izawa A., Wang P., Mukhopadhyay D., Koss K.E., Geehan C.S., Luster A.D., Sayegh M.H., and Briscoe D.M. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J. Clin. Invest. 112 (2003) 1655-1665
60. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
61. Roco M.C. Nanotechnology: convergence with modern biology and medicine. Curr. Opin. Biotechnol. 14 (2003) 337-346
62. Shah V., Cao S., Hendrickson H., Yao J., and Katusic Z.S. Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats. Am. J. Physiol.-Gastrointest. Liver Physiol. 280 (2001) G1209-G1216
63. Shimada H., Nagano M., Funakoshi T., and Kojima S. Pulmonary toxicity of systemic terbium chloride in mice. J. Toxicol. Environ. Health 48 (1996) 81-92
64. Sigel A., and Sigel H. Metal Complexes in Tumor Diagnosis and as Anticancer Agents (2004), Marcel Dekker, New York
65. Spurr A.R. A low viscosity epoxy resin embedding medium for electron microscopy. J. Ultrastruct. Res. 26 (1969) 31-36
66. Svedberg E.B., Ahner J., Shukla N., Ehrman S.H., and Schilling K. FePt nanoparticle hydrodynamic size and densities from the polyol process as determined by analytical ultracentrifugation. Nanotechnology 16 (2005) 953-956
67. Thompson K.H., and Orvig C. Editorial: Lanthanide compounds for therapeutic and diagnostic applications. Chem. Soc. Rev. 35 (2006) 499
68. Thrall J.H. Nanotechnology and medicine. Radiology 230 (2004) 315-318
69. Uckun F.M., Qazi S., Pendergrass S., Lisowski E., Waurzyniak B., Chen C.L., and Venkatachalam T.K. In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5′-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice. Antimicrob. Agents and Chemother. 6 (2002) 3428-3436
70. Wang X., and Li Y.D. Synthesis and characterization of lanthanide hydroxide single-crystal nanowires. Angew. Chem.-Int. Ed. 41 (2002) 4790-4793
71. Wu S., Ko Y.S., Teng M.S., Ko Y.L., Hsu L.A., Hsueh C., Chou Y.Y., Liew C.C., and Lee Y.S. Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. J. Mol. Cell Cardiol. 34 (2002) 1595-1607
72. Xu A.W., Fang Y.P., You L.P., and Liu H.Q. A simple method to synthesize Dy(OH)(3) and DY2O3 nanotubes. J. Am. Chem. Soc. 125 (2003) 1494-1495
73. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
74. Yu J.H., Parker D., Pal R., Poole R.A., and Cann M.J. A europium complex that selectively stains nucleoli of cells. J. Am. Chem. Soc. 128 (2006) 2294-2299
75. Zamboni W.C. Concept and clinical evaluation of carrier-mediated anticancer agents. Oncologist 13 (2008) 248-260
76. Zhang J., Campbell R.E., Ting A.Y., and Tsien R.Y. Creating new fluorescent probes for cell biology. Nat. Rev. Mol. Cell Biol. 3 (2002) 906-918